3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
3
Gastrointestinal
1
Dermatologic
1
Conditions
Melanoma
13
Gastrointestinal Stromal Tumors
3
Primary Myelofibrosis
2
Multiple Myeloma
2
Dermatofibrosarcoma
2
Chordoma
2
Carcinoma, Adenoid Cystic
2
Waldenstrom Macroglobulinemia
1
Uveal Melanoma
1
Thymoma
1
Thrombocythemia, Essential
1
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Sezary Syndrome
1
Seminoma
1
Sarcoma, Synovial
1
Sarcoma, Ewing
1
Sarcoma, Endometrial Stromal
1
Rhabdomyosarcoma, Embryonal
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Pleural Neoplasms
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Osteosarcoma
1
Neurofibrosarcoma
1
Neoplasms
1
Neoplasm Metastasis
1
Myeloproliferative Disorders
1
Mycosis Fungoides
1
Interventions
Specimen Handling
2
Nivolumab
2
entinostat
1
X-Rays
1
Phantoms, Imaging
1
Magnetic Resonance Spectroscopy
1
Ipilimumab
1
Imatinib Mesylate
1
Fentanyl
1
Cyclophosphamide
1
CTLA-4 Antigen
1
Bone Density
1
Blood Specimen Collection
1
Absorptiometry, Photon
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Desmoid Tumors
×
Imatinib Mesylate
×
Dermatologic
×
Clear all
NCT01046487
2026-03-13
PALANGI3
Centre Oscar Lambret
Phase 1
Completed
26 enrolled